help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Machinal, F.
Right arrow Articles by Giudicelli, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Machinal, F.
Right arrow Articles by Giudicelli, Y.
Endocrinology Vol. 140, No. 4 1567-1574
Copyright © 1999 by The Endocrine Society


ARTICLES

In Vivo and in Vitro ob Gene Expression and Leptin Secretion in Rat Adipocytes: Evidence for a Regional Specific Regulation by Sex Steroid Hormones

Florence Machinal, Marie-Noelle Dieudonne, Marie-Christine Leneveu, Rene Pecquery and Yves Giudicelli

Service de Biochimie, INSERM CJF 94–02, Faculté de Médecine Paris-Ouest, Université Descartes (ParisV) Centre Hospitalier de Poissy, 78303 Poissy Cedex France

Address all correspondence and requests for reprints to: Yves Giudicelli, Service de Biochimie, Centre Hospitalier, 78303 Poissy Cedex, France.


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
As a sexual dimorphism appears in plasma leptin levels, the aim of the present study was to investigate, in vivo and in vitro, the influence of sex steroid hormones on ob messenger RNA (mRNA) and leptin expressions in rat fat cells from various anatomical localizations. In male rats, castration resulted in a modulation of ob gene mRNA expression which was increased by 2-fold in perirenal and half-reduced in sc adipocytes. Moreover, in isolated fat cells from both perirenal and sc fat depots, ob gene mRNA expression was reduced by 20% after a 24-h in vitro exposure to dihydrotestosterone (10-8 M). This effect of dihydrotestosterone on ob mRNA was prevented by exposure to the antiandrogen cyproterone acetate and also by actinomycin D. In contrast, leptin secretion from both perirenal and sc adipocytes was unchanged after 24 h exposure to dihydrotestosterone. In female rats, ovariectomy induced a 25% decrease in ob gene mRNA expression in perirenal fat cells. In vitro studies revealed that a 24-h exposure to 17-ß estradiol (10-8 M) induced a 1.4-, 1.2-, and 1.75-fold increase in ob mRNA expression and a 3.8-, 1.65- and 2-fold increase in leptin secretion in sc, perirenal and parametrial adipocytes, respectively. Moreover, these effects were prevented by the antiestrogen ICI182780 and also by actinomycin D. Altogether, these results demonstrate that in rat adipocytes, estrogens, and androgens modulate ob gene expression at the mRNA level through sex steroid receptor-dependent transcriptional mechanisms.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
OBESITY, which results from an imbalance between food intake and energy expenditure, becomes a crucial problem for public health in Western countries especially. It is a major risk factor for noninsulin-dependent diabetes mellitus, hypertension, hyperlipidemia, and cardiovascular diseases. The recently cloned mouse obese (ob) gene encodes a 16-kDa circulating protein named leptin (1). Leptin, which is secreted almost exclusively by adipocytes, has been identified as a lipostatic factor that regulates the amount of body fat stores by reducing food intake and increasing energy expenditure through a negative feedback loop involving the hypothalamus (2). In fact, the anorexigen properties of leptin can be related at least in part to inhibition of the synthesis and release of the orexigen peptide neuropeptide Y (NPY) in the brain (3). Moreover, leptin messenger RNA (mRNA) and plasma leptin levels are closely associated with the body fat mass (4, 5).

Leptin acts through different types of specific receptors that are members of the cytokine receptor family (6). Leptin receptors are widely distributed including in brain and many peripheral tissues, suggesting that leptin may provide quantitative information about fat stores to a wide range of tissues.

Various hormones and drugs have been reported to regulate the leptin mRNA and protein expression. Among them, insulin (7, 8, 9, 10, 11), glucocorticoids (10, 11, 12, 13, 14), and the thyroid hormone, triiodothyronine (T3) (15, 16) are up-regulators of leptin mRNA and protein expression, whereas ß3-adrenergic agonists (17, 18) and thiazolidinediones (19, 20) are down- regulators.

It is well established that sex steroids are involved in the site-specificities of adipose tissue metabolism (21, 22, 23, 24). A sexual dimorphism seems to apply for leptin production as well because serum leptin levels are higher in premenopausal women than in both men and postmenopausal women and remain still higher in postmenopausal women than in men (25, 26).

These observations raise the question as to whether sex steroid hormones could directly or indirectly intervene in the regulation of leptin secretion and/or production by adipose cells. Different recent studies have attempted to answer this question. However, owing to the various protocols used (in vivo or in vitro investigations in human or rat models, studies of either androgen or estrogen effects, measurements of ob mRNA expression and/or leptin secretion, blood leptin, etc.), the influence of sex steroids on leptin expression and/or secretion still remains unclear. Therefore, the aim of the present study was double: 1) to investigate in the rat model, the influence of androgenic and estrogenic status on the ob gene mRNA expression in vivo and, if any, 2) to determine whether estrogens and androgens can directly modulate in vitro the ob gene mRNA expression and leptin secretion in isolated adipocytes from various fat deposits.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Materials
DMEM/Ham’s F-12 (50:50 mix), BSA, phenylmethylsulfonylfluoride (PMSF), leupeptin, vitamin E, penicillin, streptomycin, dihydrotestosterone, 17-ß estradiol, cyproterone acetate, dexamethasone and actinomycin D were purchased from Sigma Chemical Co. (St. Louis, MO). Collagenase type I (267 U/mg) was from Worthington. ICI182780 was obtained from Tocris (Bristol, UK). Superscript II Rnase H- RT was from Gibco BRL (Grand Island, NY). Taq polymerase, RNA guard and AvaII were provided by Pharmacia Biotechnology (Uppsala, Sweden). Nylon membrane Hybond N+ and random sequence hexanucleotide primers DNA labeling (Megaprime kit) were obtained from the Radiochemical Center (Amersham Corp., Buckinghamshire, UK). RIA kit specific for rat leptin was purchased from Linco Research, Inc. (St. Charles, MO).

Methods
Animals and experimental protocols. Procedures with experimental animals are authorized and followed the guidelines of the Ministère of Agriculture (France).

Sprague Dawley rats were kept under controlled lighting conditions (light, 0600 h, dark, 0800 h) and constant temperature (21 C) with free access to water and food.

Male and female rats (150 g) were gonadectomized or sham-operated (controls) as previously described (27, 28) and were killed by decapitation 2 or 3 weeks later, respectively, after an 18 h fasting. At the time they were killed, their body weights were 230–280 g.

Isolated adipocytes and culture conditions. Mature adipocytes were isolated from sc, perirenal, and parametrial adipose tissues using the collagenase digestion procedure described by Rodbell (29) with slight modifications. Following decapitation, adipose tissues were immediately removed under sterile conditions. Each fat pad was finely chopped before being transferred into the digestion solution consisting of DMEM-Ham’s F12) (50:50), collagenase 0.5–1 mg/ml, (BSA) 2%, streptomycin, 0.1 mg/ml, and penicillin, 100 U/ml.

Digestion was allowed to proceed with vigorous shaking for 30 min at 37 C, after which the completed digest was filtered through a 250 µm sterile nylon meshcone. The resulting filtrate was centrifuged for 3 min at 28 x g, the infranatant withdrawn, and the floating adipocytes washed three times with DMEM-Ham’s/F12 containing BSA 1%, streptomycin 0.1 mg/ml, and penicillin 100 U/ml before being kept in culture.

Aliquots (1 ml) of the adipocyte suspension (1–2 x 106 cells/ml) were rapidly dispensed and incubated for 24 h at 37 C under 5% CO2 and 95% air atmosphere in 5 ml of DMEM-Ham’s/F12 medium containing BSA (1.5%), leupeptin (0.2 nM), PMSF (100 nM), vitamin E (4 mg/ml), penicillin (100 U/ml), streptomycin (0.1 mg/ml) and, when indicated, the hormones and drugs tested. At the end of these incubations, adipose cells were immediately used for RNA extraction and the culture medium stored at -80 C until it was assayed for leptin.

RNA extraction. Total cellular RNA was extracted following the guanidium isothiocyanate procedure described by Chomczynski et al. (30). The yield and quality of the extracted RNA were assessed by the 260/280 nm optical density ratio and by electrophoresis under denaturing conditions on 2% agarose gel.

Northern blot analysis. Total RNA (10 µg) were separated on denaturating gels containing 1% agarose and 12.5% formaldehyde. RNAs were capillary transferred onto a Hybond N+ membrane in NaOH (0.05 N) during 3 h and cross-linked to this membrane (1 h at 80 C). Prehybridizations were carried out for 3 h at 68 C in Church solution (0.5 M sodium phosphate, 1 mM EDTA, and 7% SDS) (31). Hybridizations with [32P]-labeled complementary DNA (cDNA) probes labeled by random priming (2–5 x 108 dpm/µg) were performed overnight at 68 C. The hybridized membranes were then washed twice in 2 x SSC (30 mM Na3 citrate, 300 mM NaCl pH = 7) with 0.1% SDS at room temperature and one time at 45 C before being exposed to an x-ray film at -80 C. The band intensities were quantified by densitometry.

To verify the amounts of RNA loaded, parallel gels were run and stained with ethidium bromide (0.3 mg/ml) to visualize ribosomal RNAs (28S and 18S).

Specific rat ob and ribosomal acidic protein (RP) (32) probes were prepared by RT-PCR (33) from adipocyte total RNA. Probes were then extracted by the phenol/chloroforme extraction procedure.

RT-PCR. One-half microgram of total RNA was denatured for 10 min at 72 C and was reversed transcribed to cDNA by incubating with 10 µl RT reaction mixture containing: 50 mM Tris-HCl, 75 mM KCl, 3 mM MgCl2, 10 mM dithiothreitol, 0.5 mM of each dNTP, 62.5 mU RNA guard, 50 ng random hexamers and 100 U Superscript II reverse transcriptase. Incubation was performed at 42 C for 60 min, heated to 95 C for 5 min, and then quickly chilled on ice.

The PCR reaction mixture contained 2 µl cDNA, 0.2 mM of each dNTP, and the Taq polymerase buffer, which contained 10 mM Tris-HCl pH 8.3, 50 mM KCl, 1.5 mM MgCl2, 7.5 pM of each primer and 1.5 U of Taq polymerase.

PCR conditions were a denaturation step at 95 C for 2 min followed by 28 cycles of 95 C, 1 min; 55 C, 1 min; 72 C, 1 min. PCR were performed with a Cyclone thermocycler (Integra Bioscience, Cergy, France). PCR products were analyzed on a 2% agarose gel in 90 mM Tris-borate, 2 mM EDTA buffer (TBE), pH 8, and visualized by staining with ethidium bromide and UV transillumination.

In this semiquantitative RT-PCR method, two different primers sets were used: one primer set used for the rat ob gene had the following sequences: sense 5'-GAC ACC AAA ACC CTC ATC AAG-3' and antisense 5'-ATG TCC TGC AGA GAG CCC TG-3'. With this primer set, PCR generated a 383-bp fragment. To further characterize the amplimer, the PCR product was cleaved with AvaII. To be sure that amplification of the ob gene was within the exponential range, different numbers of PCR (20–25-28–30-32–35 cycles) were run. Finally, 28 cycles of PCR amplification were used to detect the ob mRNA.

The second primer set was specific for the rat cyclophilin gene, which is an ubiquitously housekeeping gene and can thus be used as internal standard (34). Rat cyclophilin gene specific primers had the following sequences: sense 5'-GGG AAG GTG AAA GAA GGC AT-3' and antisense 5'-GAG AGC AGA GAT TAC AGG GT-3'. With this primer set, PCR generated a 290-bp fragment of the cyclophilin gene. In the same way, different numbers of PCR cycles (25–27-29 cycles) were run. Finally, 27 cycles of PCR amplification were found to be optimal for detection of the cyclophilin mRNA.

Controls without reverse transcriptase were systematically performed to detect any cDNA contamination.

Leptin assay. Leptin levels in blood and cell incubation medium were determined with a commercially available RIA kit specific for rat leptin (35) using a rat leptin antibody produced in guinea pig. Leptin concentrations were within the detection range of the kit i.e. 0.5–50 ng leptin/ml.

Statistical analysis. All values were expressed as means ± SEM of three to four different experiments, and statistical analysis were performed using unpaired Student’s t test.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
In vivo studies
1) Regional differences in ob gene expression in both genders. Three different anatomical adipose tissue localizations were compared in this study: one superficial, the femoral sc and two intraabdominal, the perirenal and epididymal or parametrial fat deposits. Isolated adipocytes were obtained and ob gene expression analyzed by Northern blot (Fig. 1Go). In normal female rat, ob mRNA levels were higher in parametrial (1.76-fold) and perirenal (2.25-fold) than in sc adipocytes. In normal male rat, however, ob mRNA levels were not influenced by the origin of adipose tissue.



View larger version (44K):
[in this window]
[in a new window]
 
Figure 1. Ob gene expression as a function of adipose tissue regional distribution. A, Total RNA was isolated from femoral sc (sub), perirenal (per), epididymal (epi), or parametrial (para) adipocytes and from liver. Northern blots (10 µg RNA per lane) were probed with rat ob and ribosomal acidic protein (RP) probes. The figure shows one representative Northern blot and also a picture of the ethidium bromide staining to allow assessment of amount and quality of RNA. A control lane with liver total RNA is also presented but failed to reveal any specific binding. B, Densitometric analysis of ob mRNA Northern blots. Abundance of ob mRNA relative to that of RP mRNA was expressed as percentages of sc ob mRNA expression. Values are means ± SEM of three to four separate experiments. *, P < 0.05, N.S., nonsignificant

 
2) Effects of gonadectomy on ob mRNA expression. To determine whether the gonadal status may modulate leptin expression in vivo, we have studied the influence of ovariectomy and castration on adipocyte ob mRNA expression by Northern blot analysis.

As shown in Fig. 2Go, castration for 2 weeks induced a 2-fold increase in ob mRNA expression in deep adipose tissue (perirenal) and inversely a 50% decrease in ob mRNA expression in femoral sc adipose tissue. Ovariectomy for 3 weeks resulted in a 25% decrease in ob mRNA level only in adipocytes from deep localization (perirenal) and in a slight but not significant decrease in femoral sc adipocytes.



View larger version (31K):
[in this window]
[in a new window]
 
Figure 2. Effects of castration and ovariectomy on ob gene expression. A, Northern blot analysis of ob mRNA (10 µg RNA per lane) from rat sc (SUB) and perirenal (PER) adipocytes after 2 or 3 weeks gonadectomy for males and females, respectively. The figure shows one representative experiment. B, Densitometric analysis of ob mRNA Northern blot. Abundance of ob mRNA relative to that of RP mRNA was expressed as percentages of the corresponding sham-operated animals. S, Sham-operated; C, castrated; O, ovariectomized. Values are means ± SEM of three to six separate experiments. *, P < 0.05; **, P < 0.005, N.S., nonsignificant

 
These results suggesting that, in vivo, sex steroid hormones could, site-specifically, modulate ob mRNA expression, prompted us to test, in vitro, the role of sex steroid hormones.

Serum leptin levels were also compared in these animals. We found no difference between male and female rats, and between castrated or ovariectomized rats compared with the sham-operated animals, respectively (data not shown). These observations are consistent with other studies (36, 37) showing no influence of 2- to 4-week ovariectomy on rat serum leptin levels.

In vitro studies
For the following in vitro studies, ob mRNA expression was measured by a semiquantitative RT-PCR method using lower amounts of total RNA than for the Northern blot analysis. It must be noticed that when applying this RT-PCR method to the RNA preparations issued from the in vivo experiments described above, the results obtained were identical to those described in Figs. 1Go and 2Go (data not shown).

We have chosen to investigate the direct effects of androgens on leptin release and ob mRNA expression in adipocytes from normal female rats for the following reasons. First, in normal female rats plasma testosterone levels were extremely low (<0.1 ng/ml) and not different from the circulating leptin levels found in castrated rats. Second, in preliminary experiments, we did not observe any difference in the basal secretion of leptin in culture medium when deep and sc adipocytes from castrated male and normal female rats were compared. Third, we have also shown that androgen receptor numbers in adipocytes from the same anatomical origin were not influenced by sex in human (38) and in rats (unpublished data).

Deep (perirenal and parametrial) and superficial (femoral sc) adipose cells from female rats were maintained in culture and samples of culture medium were removed after 24 h for leptin secretion measurements. Adipocyte total RNAs were also extracted at the end of the 24 h incubation period and ob mRNA levels measured.

First, we studied in vitro the ob mRNA expression according to the anatomical origin of the fat cells. We confirmed our in vivo observations, i.e. a higher expression of ob gene in deep than in superficial fat pads (data not shown). Second, we examined the rate of leptin secretion as a function of the incubation time and found it linear throughout the incubation period tested (24 h) (data not shown).

We next examined the effect of dihydrotestosterone, a metabolite of testosterone that is not metabolized into estrogens, on ob expression in perirenal and femoral sc adipocytes from normal female rats. With different dihydrotestosterone concentrations (10-9, 10-8, and 10-7 M free hormone concentration) we observed a dose-dependent inhibition of ob mRNA expression (data not shown). Therefore, 10-8 M free concentration of dihydrotestosterone was selected for the following experiments.

As can be seen in Fig. 3AGo, exposure to dihydrotestosterone (10-8 M) resulted in a 25 and 30% decrease in ob mRNA expression in perirenal and sc adipocytes respectively. Under the same experimental conditions, a parallel but not significant (-20%) decrease occurred in the amount of leptin secreted into the culture medium (Table 1Go). The effects of dihydrotestosterone on ob mRNA were prevented when the adipocytes were exposed to cyproterone acetate (10-6 M), which is a potent androgen receptor antagonist, or to the transcriptional inhibitor, actinomycin D (5 µg/ml) (Fig. 3AGo). None of these compounds had an effect per se on ob mRNA. It is worth noting that incubation with dexamethasone (10-8 M) used as a positive control resulted in a 4- and 5-fold increase in leptin secretion from sc and perirenal adipocytes respectively. Furthermore, the amount of released leptin observed under control conditions, were higher in perirenal than in sc adipocytes (Table 1Go). These regional specificities of leptin secretion were correlated with the regional differences observed for ob gene expression (Fig. 1Go).



View larger version (43K):
[in this window]
[in a new window]
 
Figure 3. Effects of sex steroid hormones, in vitro, on ob mRNA expression. Total RNA was extracted and subjected to RT-PCR to determine ob mRNA levels using cyclophilin as an internal standard. The band densities were quantified using an image analyzer. A, Sc (SUB) and perirenal (PER) adipocytes from intact females were incubated for 24 h in the presence of dihydrotestosterone (DHT) alone (10-8 M) or combined with either cyproterone acetate (CYPRO) (10-6 M) or 5 µg/ml of actinomycin D (ACTINO). Respective control cells (CONT) were incubated under the same conditions but in the absence of dihydrotestosterone. Results are means ± SEM of three to five separate experiments and are normalized as percentages of the control value (no inhibitor) expressed as arbitrary units. **, P < 0.005, *, P < 0.01, N.S., nonsignificant. (a) DHT or CYPRO or ACTINO vs. CONT, (b) DHT + CYPRO vs. CYPRO, (c) DHT + ACTINO vs. ACTINO. B, Sc (SUB), perirenal (PER) and parametrial (PARA) adipocytes from ovariectomized females were incubated for 24 h in the presence of 17-ß estradiol (E2) alone (10-8 M) or combined with either ICI182780 (10-6 M) or 5 µg/ml of actinomycin D (ACTINO). Respective control cells (CONT) were incubated under the same conditions but in the absence of 17-ß estradiol. Results are means ± SEM of three to four separate experiments and are normalized as percentages of the control value (no inhibitor) expressed as arbitrary units. **, P < 0.005, *, P < 0.05, N.S., nonsignificant. (a) E2 or ICI or ACTINO vs. CONT, (b) E2 + ICI vs. ICI, (c) E2 + ACTINO vs. ACTINO.

 

View this table:
[in this window]
[in a new window]
 
Table 1. Effects of dihydrotestosterone and dexamethasone on adipocytes leptin secretion in vitro: regional differences

 
The effects of estrogens on ob mRNA expression and leptin secretion were also studied in vitro on sc, perirenal and parametrial adipocytes from ovariectomized rats because their plasma estradiol levels were very low (<1 pg/ml). As shown in Fig. 3BGo, exposure to 17-ß estradiol (10-8 M final concentration of free hormone) for 24 h led to a significant increase in ob mRNA expression in sc (+40%), perirenal (+20%) and parametrial adipose cells (+75%). Under the same conditions, the leptin released into the culture medium was increased by 65%, 109%, 288% in perirenal, parametrial and sc adipocytes, respectively (Table 2Go). Moreover, these effects of 17-ß estradiol were dose dependent (10-9, 10-8, and 10-7 M free hormone concentration) (not shown) and were prevented when the adipocytes were exposed to 17-ß estradiol and either ICI182780 (10-6 M) a selective estrogen receptor antagonist or the transcriptional inhibitor actinomycin D (5 µg/ml) (Fig. 3BGo, Fig. 4Go). None of these compounds had an effect per se on ob mRNA and leptin secretion. Finally, as described in Table 1Go, the leptin secretion was higher in deep than in sc adipocytes.


View this table:
[in this window]
[in a new window]
 
Table 2. Effects of 17-ß estradiol on adipocytes leptin secretion in vitro: regional differences

 


View larger version (41K):
[in this window]
[in a new window]
 
Figure 4. Effects of sex steroids on leptin secretion in vitro. Perirenal adipocytes from ovariectomized female rats were incubated in the presence of 17-ß estradiol (E2) alone (10-8 M) or combined with either ICI182780 (10-6 M) or 5 µg/ml of actinomycin D (ACTINO) and leptin assayed in the culture medium after 24 h of incubation. Respective control cells (CONT) were incubated under the same conditions but in the absence of 17-ß estradiol. Results are means ± SEM of three to four separate experiments and are normalized as percentages of the control value which was: no inhibitor = 7.6 ± 1.48 ng/106 cells/24 h. *, P < 0.05, N.S., nonsignificant. (a) E2 or ICI or ACTINO vs. CONT, (b) E2 + ICI vs. ICI, (c) E2 + ACTINO vs. ACTINO.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The present study demonstrates that androgens and estrogens modulate both in vivo and in vitro the ob gene expression in various white adipose tissues in rats.

Confirming previous reports (39, 40) in the rat, we have observed that the steady-state ob mRNA level, in female rat, is lower in sc than in deep abdominal adipose tissue. The same picture was observed in cultured rat adipocytes: ob mRNA levels and the amount of leptin secreted are lower with sc than with perirenal and parametrial adipocytes. These observations are completely opposed to those found in humans where several studies have demonstrated that ob mRNA level is lower in deep than in sc fat deposits (41, 42, 43).

From the present study, there are obvious regional differences in the regulation of ob gene expression by the androgenic status in vivo because castration resulted in either a decrease (-50%) or an increase (+92%) of the ob mRNA level depending on whether sc or perirenal adipocytes were tested. These discrepancies could be explained by the higher aromatase activity in sc than in perirenal adipocytes (44). Indeed, in sc fat deposit from control male rats, endogenous androgens are preferentially metabolized to estrogens, which seem to regulate positively ob mRNA level as will be discussed below. Thus, after androgen withdrawal, the positive effect of the androgens derived estrogens may disappear in sc adipocytes leading to a decrease level of ob mRNA, and at the same time, the potent negative effect of androgens in perirenal adipocytes could also disappear thus explaining the increase in ob mRNA expression.

However, no such site-related differences could be observed in our in vitro study where a 24-h exposure to the nonaromatizable metabolite of testosterone, dihydrotestosterone (10-8 M), slightly (25 to 30%) but significantly reduced the ob mRNA level in both the perirenal and sc adipocytes from normal female rats.

These effects of androgens seem to be mediated through the adipocyte androgen receptors (38, 45, 46) because cyproterone acetate, a potent antagonist of these receptors, prevents the negative influence of androgens on ob gene expression. Reduced transcription rate or decreased transcript stability may account for this modulation. The finding that actinomycin D completely prevents the negative effects of dihydrotestosterone in vitro suggests that androgens reduce ob gene expression through transcriptional mechanisms.

Under our experimental conditions, however, we have observed that the levels of ob mRNA in control cells declined by 50% between the experiment start point (time zero) and the end of incubation (24 h) (data not shown). Therefore, we cannot firmly state that the effects of androgens are solely related to transcriptional inhibition of the ob gene expression or to a decrease in the stability of the ob mRNA.

On the other hand, the nonsignificant reduction of leptin release presently observed after 24-h exposure to dihydrotestosterone could be explained by the time of exposure used as it is very short compared with another study (47) describing a negative in vitro effect of androgens on leptin secretion in differentiating human fat cells after exposure to androgens for up to 12 days. In hypogonadal men (48), clinical studies have demonstrated that at baseline, serum leptin levels were 3-fold higher than in normal men, and, after testosterone treatment serum leptin levels were completely normalized. In another recent report (49), it was demonstrated that testosterone administration in female to male transsexuals decreased median serum leptin levels. Moreover, it is now clear that men have significantly lower serum levels of leptin compared with premenopausal or postmenopausal women, even when leptin levels were corrected for differences in body composition or fat mass (37, 48, 50). These studies are consistent with our present study demonstrating a direct negative control of androgens on ob gene expression and leptin production and/or secretion in the rat.

Concerning the estrogenic status, our in vivo experiments showed that ovariectomy caused a slight decrease (-25%) in the ob mRNA level in perirenal adipocytes. These results are also consistent with the recent study of Shimizu et al. (37) who also reported reduced ob gene expression in sc and retroperitoneal adipose tissues of ovariectomized rats and its restoration to normal level by a substitutive estradiol treatment. However, this study also showed increased ob gene expression in mesenteric adipose tissue after ovariectomy, suggesting a site specificity in the way whereby the gonadal status influences ob mRNA expression. In addition, our in vitro experiments provided clear evidence that the ob mRNA is overexpressed when adipocytes from ovariectomized rats are incubated with estrogens whatever the anatomical origin of the cells. In parallel to ob mRNA overexpression, the amount of leptin secreted into the culture medium was also increased. Moreover, the effects of 17-ß estradiol on ob gene expression and leptin secretion were prevented by actinomycin D and the antiestrogen ICI182780. Because adipocytes express estrogen receptors (51, 52, 53), these findings suggest a direct transcriptional effect of estrogens on ob gene expression. Giving further weight to this suggestion are i) our observation that the ob gene promoter region includes the half-palindrome of the estrogen-responsive element (ERE) present as a functional ERE in the chicken ovalbumin gene promoter (54) and ii) one recent report, demonstrating the presence of several Sp1 responsive element in the promoter region of the ob gene (55). Thus, an estrogen-receptor (ER)-Sp1 association could represent an estrogen induced transactivation pathway that would not require direct ER binding to DNA (56). Like in the androgen studies, however, we also observed a 40–50% decrease in the steady-state ob mRNA level of control adipocytes during the 24-h incubation period. Therefore, it cannot be excluded that estrogens may also increase the ob mRNA stability. Whatsoever, our present in vivo and in vitro findings showing that estrogens regulate positively the ob gene expression, could contribute to explain why ovariectomized rats are hyperphagic and become obese (57). On the other hand, estrogen regulation of central leptin receptors should also be considered. In a recent study (58), administration of estrogens to ovariectomized rats was found to cause an increase in the leptin-RL/leptin-Rs ratio, which may enhance the hypothalamic sensitivity to leptin leading to a subsequent reduction in food intake and body weight. Thus it appears that estrogens do not solely increase the expression of ob gene in white adipocytes, the main source of leptin (our present study), but also influence the expression of the ob receptors in the hypothalamus, one of the most important targets of leptin.

In nonobese mice and humans, it has been shown that a large proportion of leptin circulates bound to several serum proteins that may facilitate the transport of leptin across the blood-brain-barrier to its hypothalamic site(s) of action (59). Another study reported higher cerebrospinal fluid/plasma leptin ratios in women than in men (60). Beside their effects on leptin expression and secretion, we actually do not know whether estrogens could also influence the turnover and/or the function of these leptin binding proteins and thus modulate further the biological effects of leptin.

Chien et al. (61) have demonstrated that serum leptin levels just like serum estrogen levels, increase with the gestational age during normal rat pregnancy and sharply decrease just before parturition. Leptin receptor mRNA levels in the uterus are also up-regulated during pregnancy, whereas they do not change in other tissues such as the kidney, liver, ovary, and lung. These observations suggest an important physiological role for leptin during pregnancy and more specifically in the regulation of energy expenditure. Taking into account the results of the present study, it can be reasonably postulated that the increase in estrogen production and secretion that occurs during pregnancy is at least in part responsible for the increase in leptin production and possibly for the leptin receptor mRNA up-regulation in uterus during pregnancy.

In conclusion, our study indicates that androgens have a negative effect and, conversely, estrogens a positive effect on leptin expression. These modulation effects are direct, mediated by the adipocyte androgen and estrogen nuclear receptors and affect the ob gene transcription. However, additional experiments will be necessary to further establish the mechanism of this regulation at the molecular level.


    Acknowledgments
 
This work was supported by INSERM (CJF 94–02), the University René Descartes Paris V, the Ligue Nationale contre le Cancer (Comité départemental des Yvelines) and Biomérieux. We wish to thank Dr. N. Lahlou for her helpful advice in conducting the leptin assays.

Received April 17, 1998.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM 1994 Positional cloning of the mouse obese gene and its human homologue. Nature 372:425–432[CrossRef][Medline]
  2. Hamann A, Matthaei S 1996 Regulation of energy balance by leptin. Exp Clin Endocrinol Diabetes 104:293–300[Medline]
  3. Stephens TW, Basinki M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM, Kriauciunas A, MacKellar W, Rosteck Jr PR, Schoner B, Smith D, Tinsley FC, Zhang X-Y, Heiman M 1995 The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377:530–532[CrossRef][Medline]
  4. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer T, Carol JF 1996 Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292–295[Abstract/Free Full Text]
  5. Harris RBS, Ramsay TG, Smith SR, Bruch RC 1996 Early and late stimulation of ob mRNA expression in meal-fed and overfed rats. J Clin Invest 97:2020–2026[Medline]
  6. Tartaglia LA, Dembski M, Weng X, Deng H, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Woolf EA, Monroe CA, Tepper RI 1995 Identification and expression cloning of a leptin receptor, OB-R. Cell 83:1263–1271[CrossRef][Medline]
  7. MacDougald OA, Hwang C, Fan H, Lane MD 1995 Regulated expression of the obese gene product (leptin) in white adipose tissue and 3T3–L1 adipocytes. Proc Natl Acad Sci USA 92:9034–9037[Abstract/Free Full Text]
  8. Saladin R, DeVos P, Guerre-Millo M, Leturque A, Girard JM, Ailhaud G, Dani C 1995 Transient increase in obese gene expression after food intake or insulin administration. Nature 377:527–529[CrossRef][Medline]
  9. Leroy P, Dessolin S, Villageois P, Moon BC, Friedman JM, Ailhaud G, Dani C 1996 Expression of ob gene in adipose cells: regulation by insulin. J Biol Chem 271:2365–2368[Abstract/Free Full Text]
  10. Yoshida T, Hayashi M, Monkawa T, Saruta T 1996 Regulation of obese mRNA expression by hormonal factors in primary cultures of rat adipocytes. Eur J Endocrinol 135:619–625[Abstract]
  11. Wabitsch M, Jensen PB, Blum WF, Christoffersen CT, Englaro P, Heinze E, Rascher W, Teller W, Tornqvist H, Hauner H 1996 Insulin and cortisol promote leptin production in cultured human fat cells. Diabetes 45:1435–1438[Abstract]
  12. DeVos P, Saladin R, Auwerx J, Staels B 1995 Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. J Biol Chem 270:15958–15961[Abstract/Free Full Text]
  13. Murakami T, Iida M, Shima K 1995 Dexamethasone regulates obese expression in isolated rat adipocytes. Biochem Biophys Res Commun 214:1260–1267[CrossRef][Medline]
  14. Slieker LJ, Sloop KW, Surface PL, Kriauciunas A, LaQuier F, Manetta J, Bue-Valleskey J, Stephans TW 1996 Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. J Biol Chem 271:5301–5304[Abstract/Free Full Text]
  15. Yoshida T, Monkawa T, Hayashi M, Saruta T 1997 Regulation of expression of leptin mRNA and secretion of leptin by thyroid hormone in 3T3–L1 adipocytes. Biochem Biophys Res Commun 232:822–826[CrossRef][Medline]
  16. Fain JN, Coronel EC, Beauchamp MJ, Bahouth SW 1997 Expression of leptin and ß3-adrenergic receptors in rat adipose tissue in altered thyroid states. Biochem J 322:145–150
  17. Giacobino J-P 1996 Role of the ß3-adrenoceptor in the control of leptin expression. Horm Metab Res 28:633–637[Medline]
  18. Mantzoros CS, Qu D, Frederich RC, Susulic VS, Lowell BB, Maratos-Flier E, Flier JS 1996 Activation of ß3 adrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice. Diabetes 45:909–914[Abstract]
  19. Zhang B, Graziano MP, Doebber TW, Leibowitz MD, White-Carrington S, Szalkowski DM, Hey PJ, Wu M, Cullinan CA, Bailey P, Lollmann B, Frederich R, Flier JS, Strader CD, Smith RG 1996 Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice. J Biol Chem 271:9455–9459[Abstract/Free Full Text]
  20. Kallen CB, Lazar MA 1996 Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3–L1 adipocytes. Proc Natl Acad Sci USA 93:5793–5796[Abstract/Free Full Text]
  21. Vague J 1947 La différenciation sexuelle, facteur déterminant des formes de l’obésité. Presse Med 53:339–340
  22. Rebuffe-Scrive M, Lonnroth P, Wesslau MC, Bjorntorp P 1987 Regional adipose tissue metabolism in men and post menopausal women. Int J Obes 11:347–355[Medline]
  23. Lacasa D, Agli B, Pecquery R, Giudicelli Y 1991 Influence of ovariectomy and regional fat distribution on the membranous transducing system controlling lipolysis in fat cells. Endocrinology 128:747–753[Abstract]
  24. Lacasa D, Garcia E, Agli B, Giudicelli Y 1997 Control of rat preadipocytes adipose conversion by ovarian status: regional specificity and possible involvement of the mitogen-activated protein kinase-dependent and c-fos signaling pathways. Endocrinology 138:2729–2734[Abstract/Free Full Text]
  25. Rosenbaum M, Nicolson M, Hirsch J, Heymsfield BB, Gallagher D, Chu F, Leibel RL 1996 Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 81:3424–3427[Abstract]
  26. Saad MF, Damani S, Gingerich RL, Riadgabriel MG, Khan A, Boyadjian R, Jinagouda SD, Eltawil K, Rude RK, Kamdar V 1997 Sexual dimorphism in plasma leptin concentration. J Clin Endocrinol Metab 82:579–584[Abstract/Free Full Text]
  27. Pecquery R, Leneveu M-C, Giudicelli Y 1988 Influence of androgenic status on the {alpha}2/ß-adrenergic control of lipolysis in white fat cells: predominant {alpha}2-antilipolytic response in testosterone-treated-castrated hamsters. Endocrinology 122:2590–2596[Abstract]
  28. Lacasa D, Agli B, Pecquery R, Giudicelli Y 1991 Influence of ovariectomy and regional fat distribution on the membranous transducing system controlling lipolysis in rat fat cells. Endocrinology 128:747–753
  29. Rodbell M 1964 Metabolism of isolated fat cells. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 239:375–380[Free Full Text]
  30. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159[Medline]
  31. Church GM, Gilbert W 1984 Genomic sequencing. Proc Natl Acad Sci USA 81:1991–1995[Abstract/Free Full Text]
  32. Laborda J 1991 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res 19:3998[Free Full Text]
  33. Saiki RK, Gelfand DH, Stoffei S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA 1988 Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487–491[Abstract/Free Full Text]
  34. Zamorano PL, Mahesh VB, De Sevilla LM, Chorich LP, Bhat GK, Brann DW 1997 Expression and localization of the leptin receptor in endocrine and neuroendocrine tissues of the rat. Neuroendocrinology 65:223–228[CrossRef][Medline]
  35. Ma Z, Gingerich RL, Santiago JV, Klein S, Smith CH, Landt M 1996 Radioimmunoassay of leptin in human plasma. Clin Chem 42:942–946[Abstract/Free Full Text]
  36. Yoneda N, Saito S, Kimura M, Yamada M, Iida M, Murakami T, Irahara M, Shima K, Aono T 1998 The influence of ovariectomy on ob gene expression in rats. Horm Metab Res 30:263–265[Medline]
  37. Shimizu H, Shimomura Y, Nakanishi Y, Futawatari T, Ohtani K, Sato N, Mori M 1997 Estrogen increases in vivo leptin production in rats and human subjects. J Endocrinol 154:285–292[Abstract]
  38. Dieudonné M-N, Pecquery R, Boumedienne A, Leneveu M-C, Giudicelli Y 1998 Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids. Am J Physiol 274:C1645–C1652
  39. Zheng D, Jones JP, Usala SJ, Dohm GL 1996 Differential expression of ob mRNA in rat adipose tissues in response to insulin. Biochem Biophys Res Commun 218:434–437[CrossRef][Medline]
  40. Masuzaki H, Ogawa Y, Shigemoto M, Satoh N, Mori K, Tamura N, Hosoda K, Yoshimasa Y, Jingami H, Nakao K 1995 Adipose tissue-specific expression of the obese (ob) gene in rats and its marked augmentation in genetically obese-hyperglycemic Wistar fatty rats. Proc Jpn Acad 71:148–152
  41. Masuzaki H, Ogawa Y, Isse N, Satoh N, Okazaki T, Shigemoto M, Mori K, Tamura N, Hosoda K, Yoshimasa Y, Jingami H, Kawada T, Nakao K 1995 Human obese gene expression. Adipocyte-specific expression and regional differences in the adipose tissue. Diabetes 44:855–858[Abstract]
  42. Hube F, Lietz U, Igel M, Jensen PB, Tornqvist H, Joost H G, Hauner H 1996 Difference in leptin mRNA levels between omental and subcutaneous abdominal adipose tissue from obese humans. Horm Metab Res 28:690–693[Medline]
  43. Montague CT, Prins JB, Sanders L, Digby JE, O’Rahilly S 1997 Depot-and sex-specific differences in human leptin mRNA expression. Diabetes 46:342–347[Abstract]
  44. Bulun SE, Simpson ER 1994 Competitive reverse transcription-polymerase chain reaction analysis indicates that levels of aromatase cytochrome P450 transcripts in adipose tissue of buttocks, thighs, and abdomen of women increase with advancing age. J Clin Endocrinol Metab 78:428–432[Abstract]
  45. Xu X, De Pergola G, Björntorp P 1990 The effect of androgens on the regulation of lipolysis in adipose precursors cells. Endocrinology 126:1229–1234[Abstract]
  46. Dieudonné M-N, Pecquery R, Leneveu M-C, Jaubert A-M, Giudicelli Y 1995 Androgen receptors in cultured rat adipose precursor cells during proliferation and differentiation: regional specificities and regulation by testosterone. Endocrine 3:537–541
  47. Wabitsch M, Blum WF, Muche R, Braun M, Hube F, Rascher W, Heinze E, Teller W, Hauner H 1997 Contribution of androgens to the gender difference in leptin production in obese children and adolescents. J Clin Invest 100:808–813[Medline]
  48. Jockenhövel F, Blum WF, Vogel E, Englaro P, Müller-Wieland D, Reinwein D, Rascher W, Krone W 1997 Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men. J Clin Endocrinol Metab 82:2510–2513[Abstract/Free Full Text]
  49. Elbers JMH, Asscheman H, Seidell JC, Frölich M, Meinders AE, Gooren LJ G 1997 Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals. J Clin Endocrinol Metab 82:3267–3270[Abstract/Free Full Text]
  50. Rosenbaum M, Nicolson M, Hirsch J, Heymsfield S B, Gallagher D, Chu F, Leibel RL 1996 Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 81:3424–3427
  51. Gray MJ, Dudley SD, Wade GN 1981 In vivo cell nuclear binding of 17 ß-(3H) estradiol in rat adipose tissues. Am J Physiol 240:E43–E46
  52. Pedersen SD, Borglum JD, Moller-Pedersen T, Richelsen B 1992 Effects of in vitro estrogen treatment on adipose tissue metabolism and nuclear estrogen receptor binding in isolated rat adipocytes. Mol Cell Endocrinol 85:13–19[CrossRef][Medline]
  53. Price TM, O’Brien S 1993 Determination of estrogen receptor messenger ribonucleic acid (mRNA) and cytochrome P450 aromatase mRNA levels in adipocytes and adipose stromal cells by competitive polymerase chain reaction amplification. J Clin Endocrinol Metab 77:1041–1045[Abstract]
  54. Tora L, Gaub M-P, Mader S, Dierich A, Bellard M, Chambon P 1988 Cell-specific activity of a GGTCA half-palindromic estrogen-responsive element in the chicken ovalbumin gene promoter. EMBO J 7:3771–3778[Medline]
  55. Gong DW, Bi S, Pratley RE, Weintraub BD 1996 Genomic structure and promoter analysis of the human obese gene. J Biol Chem 271:3971–3974[Abstract/Free Full Text]
  56. Porter W, Saville B, Hoivik D, Safe S 1997 Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol Endocrinol 11:1569–1580[Abstract/Free Full Text]
  57. Wade GN 1972 Gonadal hormones and behavioral regulation of body weight. Physiol Behav 8:523–534[CrossRef][Medline]
  58. Bennett PA, Lindell K, Karlsson C, Robinson ICAF, Carlsson LMS, Carlsson B 1998 Differential expression and regulation of leptin receptor isoforms in the rat brain: effects of fasting and estrogen. Neuroendocrinology 67:29–36[CrossRef][Medline]
  59. Houseknecht KL, Mantzoros CS, Kuliawat R, Hadro E, Flier J S 1996 Evidence for leptin binding to proteins in serum of rodents and humans: modulation with obesity. Diabetes 45:1638–1643[Abstract]
  60. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte Jr D 1996 Cerebrospinal fluid leptin: relationship to plasma levels, and to adiposity in humans. Nature Med 2:589–593[CrossRef][Medline]
  61. Chien EK, Hara M, Rouard M, Yano H, Philippe M, Polonsky KS, Bell GI 1997 Increase in serum leptin and uterine leptin receptor messenger RNA levels during pregnancy in rats. Biochem Biophys Res Commun 237:476–480[CrossRef][Medline]



This article has been cited by other articles:


Home page
EndocrinologyHome page
I-C. Yu, H.-Y. Lin, N.-C. Liu, R.-S. Wang, J. D. Sparks, S. Yeh, and C. Chang
Hyperleptinemia without Obesity in Male Mice Lacking Androgen Receptor in Adipose Tissue
Endocrinology, May 1, 2008; 149(5): 2361 - 2368.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
E. Dos Santos, M.-N. Dieudonne, M.-C. Leneveu, R. Pecquery, V. Serazin, and Y. Giudicelli
In vitro effects of chorionic gonadotropin hormone on human adipose development
J. Endocrinol., August 1, 2007; 194(2): 313 - 325.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
S. R. Thorn, M. J. Meyer, M. E. Van Amburgh, and Y. R. Boisclair
Effect of Estrogen on Leptin and Expression of Leptin Receptor Transcripts in Prepubertal Dairy Heifers
J Dairy Sci, August 1, 2007; 90(8): 3742 - 3750.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A.-M. Jaubert, N. Mehebik-Mojaat, D. Lacasa, D. Sabourault, Y. Giudicelli, and C. Ribiere
Nongenomic Estrogen Effects on Nitric Oxide Synthase Activity in Rat Adipocytes
Endocrinology, May 1, 2007; 148(5): 2444 - 2452.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
A. Alonso, R. Fernandez, M. Moreno, P. Ordonez, F. Diaz, and C. Gonzalez
Leptin and Its Receptor Are Controlled by 17{beta}-Estradiol in Peripheral Tissues of Ovariectomized Rats
Experimental Biology and Medicine, April 1, 2007; 232(4): 542 - 549.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
A M Lorincz and S Sukumar
Molecular links between obesity and breast cancer.
Endocr. Relat. Cancer, June 1, 2006; 13(2): 279 - 292.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. J. Clegg, L. M. Brown, S. C. Woods, and S. C. Benoit
Gonadal hormones determine sensitivity to central leptin and insulin.
Diabetes, April 1, 2006; 55(4): 978 - 987.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. C. Henson and V. D. Castracane
Leptin in Pregnancy: An Update
Biol Reprod, February 1, 2006; 74(2): 218 - 229.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
M. Lappas, K. Yee, M. Permezel, and G. E Rice
Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies
J. Endocrinol., September 1, 2005; 186(3): 457 - 465.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Monjo, E. Pujol, and P. Roca
{alpha}2- to {beta}3-Adrenoceptor switch in 3T3-L1 preadipocytes and adipocytes: modulation by testosterone, 17{beta}-estradiol, and progesterone
Am J Physiol Endocrinol Metab, July 1, 2005; 289(1): E145 - E150.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H.-Y. Lin, Q. Xu, S. Yeh, R.-S. Wang, J. D. Sparks, and C. Chang
Insulin and Leptin Resistance With Hyperleptinemia in Mice Lacking Androgen Receptor
Diabetes, June 1, 2005; 54(6): 1717 - 1725.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. D. Veldhuis, J. N. Roemmich, E. J. Richmond, A. D. Rogol, J. C. Lovejoy, M. Sheffield-Moore, N. Mauras, and C. Y. Bowers
Endocrine Control of Body Composition in Infancy, Childhood, and Puberty
Endocr. Rev., February 1, 2005; 26(1): 114 - 146.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
V. Giusti, M. Suter, C. Verdumo, R. C. Gaillard, P. Burckhardt, and F. P. Pralong
Molecular Determinants of Human Adipose Tissue: Differences between Visceral and Subcutaneous Compartments in Obese Women
J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1379 - 1384.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
M. R. Garcia, M. Amstalden, S. W. Williams, R. L. Stanko, C. D. Morrison, D. H. Keisler, S. E. Nizielski, and G. L. Williams
Serum leptin and its adipose gene expression during pubertal development, the estrous cycle, and different seasons in cattle
J Anim Sci, August 1, 2002; 80(8): 2158 - 2167.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. G. Geisler, W. Zawalich, K. Zawalich, J. R.T. Lakey, H. Stukenbrok, A. J. Milici, and W. C. Soeller
Estrogen Can Prevent or Reverse Obesity and Diabetes in Mice Expressing Human Islet Amyloid Polypeptide
Diabetes, July 1, 2002; 51(7): 2158 - 2169.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
F. Machinal-Quelin, M. N. Dieudonne, M. C. Leneveu, R. Pecquery, and Y. Giudicelli
Proadipogenic effect of leptin on rat preadipocytes in vitro: activation of MAPK and STAT3 signaling pathways
Am J Physiol Cell Physiol, April 1, 2002; 282(4): C853 - C863.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. S. Torday, H. Sun, L. Wang, and E. Torres
Pre- and Postnatal Lung Development, Maturation, and Plasticity: Leptin mediates the parathyroid hormone-related protein paracrine stimulation of fetal lung maturation
Am J Physiol Lung Cell Mol Physiol, March 1, 2002; 282(3): L405 - L410.
[Abstract] [Full Text]